Price
No data yet.
Social Signal Score
Analyst Ratings
26 analystsRevenue
$1.52B+666.93%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Timothy O'Rourke
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 856
- Beta
- 3.11
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 2.73
Financials
Revenue
$1.52B+666.9%Net Income
$34.91MEBITDA
$47.40MFree Cash Flow
$46.62MEPS (diluted)
$1.97Shares Outstanding (diluted)
17.69M+15.1%Operating Expenses
$67.13MCash & Debt
$239.76MReturn of Capital
$0.00Revenue by Segment (annual)
$5.93BDividend per Share
$0.45Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.93B | $-405.35M | $-24.50 |
| 2024 | $6.06B | $-260.15M | $-15.75 |
| 2023 | $4.32B | $-262.60M | $-16.00 |
| 2022 | $2.39B | $-106.55M | $-6.50 |
| 2021 | $1.52B | $-406.49M | $-27.25 |
| 2020 | $1.22B | $-60.05M | $-4.00 |
| 2019 | $794.41M | $-282.59M | $-18.50 |
Valuation
AGLhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120-20.00%Social Signal Score
Mentions (11)
- Newszacks.com·3d ago·Positive
Best Momentum Stocks to Buy for November 19th AGL, AIZ and KROS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 19th, 2026.
View source ↗ - Newszacks.com·3d ago·Positive
New Strong Buy Stocks for November 19th KROS, AIZ, AGL, EQNR and PANL have been added to the Zacks Rank #1 (Strong Buy) List on November 19th, 2026.
View source ↗ - Newsseekingalpha.com·5d ago·Positive
agilon health: Same Doctors, Higher Risk Scores, Thinner Reserve agilon health is rated HOLD with a 12-month price target of $98, 14.6% below the $114.81 close. Rising patient risk scores, especially in Ohio and Texas ACOs, drove about half of AGL's 2026 margin upgrade, but sustainability is uncertain. Recent years saw risk-score revenue volatility and the leanest claims reserve in five years, raising questions about future earnings consistency.
View source ↗ - Newszacks.com·6d ago·Neutral
Agilon Health (AGL) Is Up 2.00% in One Week: What You Should Know Does Agilon Health (AGL) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗ - Newszacks.com·6d ago·Positive
Best Momentum Stocks to Buy for November 16th AGL, GMRS and PH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 16th, 2026.
View source ↗ - Newsmarketbeat.com·17d ago·Neutral
Agilon Health Q3 Earnings Call Highlights Agilon Health NYSE: AGL raised its full-year 2026 outlook after reporting third-quarter results that exceeded its guidance, driven by higher risk-adjustment revenue, clinical program performance and favorable medical cost development in the first half of the year.
View source ↗ - Newszacks.com·18d ago·Negative
Compared to Estimates, Agilon (AGL) Q3 Earnings: A Look at Key Metrics The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
View source ↗ - Newszacks.com·18d ago·Neutral
Agilon Health (AGL) Q3 Earnings and Revenues Surpass Estimates Agilon Health (AGL) came out with quarterly earnings of $1.97 per share, beating the Zacks Consensus Estimate of a loss of $2.01 per share. This compares to a loss of $6.75 per share a year ago.
View source ↗ - Newsseekingalpha.com·18d ago·Positive
agilon health, inc. (AGL) Q3 2026 Earnings Call Transcript agilon health, inc. (AGL) Q3 2026 Earnings Call Transcript
View source ↗ - Newsbusinesswire.com·94d ago·Neutral
agilon health to Participate in Upcoming Conferences WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the following conferences: Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026. 2026 Jefferies Healthcare Services and Technology Conference on Monday, September 14, 2026. A live webcas…
View source ↗ - Newsreuters.com·103d ago·Negative
Australia's AGL Energy logs nearly 2% fall in annual profit Australian power producer AGL Energy reported a nearly 2% fall in its annual underlying profit on Wednesday, pressured by higher gas supply costs and lower wholesale electricity prices.
View source ↗
Earnings
Wed, Feb 24(in 3 months)
Consensus estimate $-3.26 per share
Typical surprise +59.3% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Nov 4$1.97 vs $-1.23beat
- Wed, Aug 5$1.04 vs $0.14beat
- Wed, May 6$1.80 vs $1.13beat
- Wed, Feb 25$-11.50 vs $-6.75miss
- Tue, Nov 4$-6.75 vs $-3.73miss
- Tue, Aug 5$-6.25 vs $-2.75miss
Estimates and results for AGL via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by AGL officers and directors.
- Bought
- $918k
- Sold
- —
12 trades
0 trades
- Shaker Benjaminbought
- Wulf John Williambought
- Sell Stevenbought
- Shaker Benjaminbought
- Venkatachaliah Girishbought
- Mcloughlin Karenbought
- Battaglia Silvanabought
- Mckenzie Dianabought
88 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in AGL.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
